Literature DB >> 8401933

Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic beta-cells.

M Kakei1, M Nakazaki, T Kamisaki, I Nagayama, Y Fukamachi, H Tanaka.   

Abstract

1. Cibenzoline, a class I antiarrhythmic agent, was investigated for its effect on the ATP-sensitive K+ channel of pancreatic beta-cells by the patch clamp technique. 2. In perforated patch clamp experiments, cibenzoline depolarized the membrane of single beta-cells and thereafter, caused firing of action potentials in the presence of 2.8 mM glucose. 3. Cibenzoline inhibited the activity of the ATP-sensitive K+ channel in cell-attached recordings in the presence of 2.8 mM glucose and evoked repetitive fluctuations of the baseline current, apparently reflecting the action potentials of the beta-cell. 4. In whole-cell clamp experiments, time-independent outward current was induced by depleting cytoplasmic ATP with 0.1 mM ATP and 0.1 mM ADP in the solution contained in the pipette. The outward current was inhibited by cibenzoline in a dose-dependent manner in the concentration range of 1 microM to 100 microM and half maximum inhibition occurred at 1.5 microM. 5. Cibenzoline blocked substantially the ATP-sensitive K+ channel current when applied at the inner side of the membrane in isolated inside-out membrane patches. 6. It is concluded that cibenzoline blocks the ATP-sensitive K+ channel of pancreatic beta-cells and, thereby, stimulates insulin secretion at sub-stimulatory levels of glucose.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401933      PMCID: PMC2175729          DOI: 10.1111/j.1476-5381.1993.tb13753.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Glucose dependent K+-channels in pancreatic beta-cells are regulated by intracellular ATP.

Authors:  P Rorsman; G Trube
Journal:  Pflugers Arch       Date:  1985-12       Impact factor: 3.657

2.  Pharmacokinetics of cibenzoline after single and repetitive dosing in healthy volunteers.

Authors:  J W Massarella; K C Khoo; A J Szuna; D A Sandor; J Morganroth; K Aogaichi
Journal:  J Clin Pharmacol       Date:  1986-02       Impact factor: 3.126

3.  Intracellular ATP directly blocks K+ channels in pancreatic B-cells.

Authors:  D L Cook; C N Hales
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

Review 5.  Significance of ionic fluxes and changes in membrane potential for stimulus-secretion coupling in pancreatic B-cells.

Authors:  J C Henquin; H P Meissner
Journal:  Experientia       Date:  1984-10-15

6.  Amantadine and sparteine inhibit ATP-regulated K-currents in the insulin-secreting beta-cell line, HIT-T15.

Authors:  F M Ashcroft; A J Kerr; J S Gibson; B A Williams
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

7.  The sulphonylurea receptor may be an ATP-sensitive potassium channel.

Authors:  N C Sturgess; M L Ashford; D L Cook; C N Hales
Journal:  Lancet       Date:  1985-08-31       Impact factor: 79.321

8.  Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells.

Authors:  F M Ashcroft; D E Harrison; S J Ashcroft
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

9.  Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in rats.

Authors:  G Bertrand; R Gross; P Petit; M M Loubatières-Mariani; G Ribes
Journal:  Eur J Pharmacol       Date:  1992-04-22       Impact factor: 4.432

10.  Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline.

Authors:  M Holck; W Osterrieder
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

View more
  4 in total

1.  Block of pancreatic ATP-sensitive K+ channels and insulinotrophic action by the antiarrhythmic agent, cibenzoline.

Authors:  A Ishida-Takahashi; M Horie; Y Tsuura; H Ishida; T Ai; S Sasayama
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

2.  Cibenzoline, an ATP-sensitive K(+) channel blocker, binds to the K(+)-binding site from the cytoplasmic side of gastric H(+),K(+)-ATPase.

Authors:  Y Tabuchi; H Yashiro; S Hoshina; S Asano; N Takeguchi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  The effects of flecainide on ATP-sensitive K(+) channels in pig urethral myocytes.

Authors:  T Yunoki; N Teramoto; S Naito; Y Ito
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

4.  Lipophilicity predicts the ability of nonsulphonylurea drugs to block pancreatic beta-cell KATP channels and stimulate insulin secretion; statins as a test case.

Authors:  Joana Real; Caroline Miranda; Charlotta S Olofsson; Paul A Smith
Journal:  Endocrinol Diabetes Metab       Date:  2018-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.